1
1

index-about
社團法人台灣肝病醫療策進會Advancing Clinical Treatment – Liver Disease (ACT-LD) 為一國際權威肝病防治組織,成立目標即在於藉由提升民眾對於肝病的認知,加強醫學界對肝病相關重大進展的了解,來改善病人的照顧品質與治療結果。2004年台灣肝病醫療策進會於美國成立運作,2005年年初擴展到B型肝炎盛行之亞太地區,分別在亞太十四個國家成立分會。一向對台灣肝病防治不遺餘力、成績有目共睹的台灣,也於2005年11月29日正式宣布台灣分會成立。

聯合報- 健保C肝新藥醫院名額今早用罄 診所名額還有600多個

| 最新消息 | No Comments
政府今年初給付C型肝炎全口服新藥,總計有9929個名額(醫院...

C肝新藥續納健保 擬編48億

| 最新消息 | No Comments
C肝新藥明年續納健保!健保署提出草案,明年健保總額將以「其他...

On 28 May, 194 Member States made a historic commitment to eliminate viral hepatitis by 2030. At the 69th World Health Assembly, governments unanimously voted to adopt the first ever Global Viral Hepatitis Strategy, signalling the greatest global commitment in viral hepatitis to date. The Strategy sets a goal of eliminating hepatitis B and C by 2030 and includes a set of prevention and treatment targets which, if reached, will reduce annual deaths by 65% and increase treatment to 80%, saving 7.1 million lives globally by 2030. Share this video and support NOhep.org on World Hepatitis Day (28 July 2016) to ensure governments countries honour their commitment to making the elimination of viral hepatitis our next greatest achievement.